| Name | 2-bromo-1,3-thiazole-4-carbonitrile |
|---|---|
| Synonyms |
2-bromothiazole-4-carbonitrile
4-Thiazolecarbonitrile, 2-bromo- 2-Bromo-1,3-thiazole-4-carbonitrile 2-BROMO-4-CYANOTHIAZOLE |
| Density | 2.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 276.1±13.0 °C at 760 mmHg |
| Molecular Formula | C4HBrN2S |
| Molecular Weight | 189.033 |
| Flash Point | 120.8±19.8 °C |
| Exact Mass | 187.904373 |
| PSA | 64.92000 |
| LogP | 1.36 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.651 |
| HS Code | 2934100090 |
|---|
|
~%
848501-90-6 |
| Literature: WO2011/109799 A1, ; Page/Page column 225 ; |
|
~%
848501-90-6 |
| Literature: KARYOPHARM THERAPEUTICS, INC.; SHECHTER, Sharon; KAUFFMAN, Michael; SANDANYAKA, Vincent, P.; SHACHAM, Sharon Patent: WO2011/109799 A1, 2011 ; Location in patent: Page/Page column 225 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |